ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVCR announcements Novocure Limited announcements and dividends declared NASDAQ

Novocure Limited Complete list of announcements declared & dividend announcements by Novocure Limited NVCR

Novocure Limited NVCR listed on NASDAQ and deals in Health Care Medical Dental Instruments

Announcements and dividends declared by Novocure Limited NVCR

Why NovoCure Stock Leaped 4% Higher Today
Thursday morning NovoCure (NASDAQ: NVCR) published its first set of quarterly results for 2025, and they pleased more than a few investors. With that tailwind, the biotech's stock price rose in excess of 4%, easily topping the slightly over 2% increase of
Announcement as on 24 April 2025

Prediction: Novocure (NVCR) Will Beat the Market. Here's Why
Explore the exciting world of NovoCure (NASDAQ: NVCR) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the
Announcement as on 05 March 2025

NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock?
NovoCure NVCR shares ended the last trading session 12% higher at .64. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 19.8% loss ove
Announcement as on 28 March 2024

Down 31% in 1 Day, What's Next for NovoCure Stock?
After its stock fell 31% on Aug. 28, leaving it down by 72% in the last 12 months, NovoCure (NASDAQ: NVCR) shareholders are bound to be quite displeased. The cancer-treating device maker remains unprofitable despite having its Optune portable therapy machi
Announcement as on 04 September 2023

: Novocure shares plunge after ovarian cancer study failure
Shares of Novocure Ltd. NVCR dropped 37% premarket on Monday after the Swiss oncology company said a late-stage trial of Tumor Treating Fields with paclitaxel failed to meet its primary endpoint of overall survival in patients with ovarian cancer. Tumor tr
Announcement as on 28 August 2023

Announcements by Novocure Limited first page | Next page |

NVCR Novocure Limited current price & indicator signals

Moving Averages for Novocure Limited

  • 5Day Average: 11.66
  • 12Day Average: 11.99
  • 20Day Average: 11.74
  • 50Day Average: 12.79
  • 100Day Average: 12.63
  • 150Day Average: 14.29
  • 200Day Average: 15.29

NVCR Indicators & signals

Indicator MACD (12,26,9)

11.92, 12.09, -0.24
Indicator MACD is in negative zone

Indicator ADX (14)

24.14, 17.19, 28.13
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVCR Novocure Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 12.11 11.74 to 12.21 2.98% 1.19 times
04 Thu Dec 2025 11.76 11.36 to 11.83 -0.42% 0.94 times
03 Wed Dec 2025 11.81 10.93 to 11.86 8.15% 1.23 times
02 Tue Dec 2025 10.92 10.79 to 11.84 -6.51% 1.52 times
01 Mon Dec 2025 11.68 11.48 to 12.57 -8.82% 1.65 times
28 Fri Nov 2025 12.81 12.61 to 12.89 0.39% 0.39 times
26 Wed Nov 2025 12.76 12.53 to 12.82 0.95% 0.65 times
25 Tue Nov 2025 12.64 12.45 to 12.68 0.88% 0.77 times
24 Mon Nov 2025 12.53 11.92 to 12.56 4.85% 0.93 times
21 Fri Nov 2025 11.95 11.38 to 12.17 4.28% 1.05 times
20 Thu Nov 2025 11.46 11.44 to 12.13 0.09% 0.86 times
19 Wed Nov 2025 11.45 11.14 to 11.57 0% 0.71 times

Videos related to: NVCR announcements Novocure Limited announcements and dividends declared NASDAQ

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVCR announcements Novocure Limited announcements and dividends declared NASDAQ

 

Back to top